Ezra Full Body MRI Scan
The whole-body MRI alternative to Prenuvo — same protocol, lower price tier.
The whole-body MRI competitor to Prenuvo — Ezra opens scanning to a wider price tier and uses AI for radiologist-augmented reading.
Ezra is the second major player (alongside Prenuvo) in the consumer whole-body MRI market. Same general protocol — full-body imaging, no contrast required, looking for incidental findings traditional preventive care misses. Ezra differentiates on price tiers (multi-tier scanning options $1,495-$2,495 vs Prenuvo's $999-$2,499 typical range) and on AI-augmented reading workflows where their AI tools assist radiologists in finding subtle abnormalities.
The controversy that applies to both Ezra and Prenuvo: high false-positive rate. Catching incidental findings often generates worry that outweighs the actual clinical utility. Major medical societies don't endorse whole-body MRI as routine preventive screening. For buyers with personal or family cancer history, the math may favor it; for everyone else, it's a buyer-preference decision.
For longevity-focused buyers wanting whole-body imaging in their stack, Ezra and Prenuvo are roughly comparable. The decision often comes down to which has scanners closer to your location.
Longevity-focused buyers wanting whole-body imaging at a structured price tier. Buyers who specifically want AI-augmented reading. People with family cancer history wanting comprehensive screening.
You're skeptical of the whole-body-MRI value proposition (high false-positive rate is real), or your insurance covers targeted imaging that addresses your specific risks.